Effects of vedolizumab, adalimumab and infliximab on biliary inflammation in individuals with primary sclerosing cholangitis and inflammatory bowel disease (Q88887148)
Jump to navigation
Jump to search
scientific article published on 28 May 2018
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effects of vedolizumab, adalimumab and infliximab on biliary inflammation in individuals with primary sclerosing cholangitis and inflammatory bowel disease |
scientific article published on 28 May 2018 |
Statements
Effects of vedolizumab, adalimumab and infliximab on biliary inflammation in individuals with primary sclerosing cholangitis and inflammatory bowel disease (English)
L E Raffals